Antidepressant Use Before and After the Diagnosis of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine antidepressant use before and after the diagnosis of diabetes. RESEARCH DESIGN AND METHODS: This study was a longitudinal analysis of diabetic and nondiabetic groups selected from a prospective cohort study of 151,618 men and women in Finland (the Finnish Public Sector Study, 1995–2005). We analyzed the use of antidepressants in those 493 individuals who developed type 2 diabetes and their 2,450 matched nondiabetic control subjects for each year during a period covering 4 years before and 4 years after the diagnosis. For comparison, we undertook a corresponding analysis on 748 individuals who developed cancer and their 3,730 matched control subjects. RESULTS: In multilevel longitudinal models, the odds ratio for antidepressant use in those who developed diabetes was 2.00 (95% CI 1.57–2.55) times greater than that in nondiabetic subjects. The relative difference in antidepressant use between these groups was similar before and after the diabetes diagnosis except for a temporary peak in antidepressant use at the year of the diagnosis (OR 2.66 [95% CI 1.94–3.65]). In incident cancer case subjects, antidepressant use substantially increased after the cancer diagnosis, demonstrating that our analysis was sensitive for detecting long-term changes in antidepressant trajectories when they existed. CONCLUSIONS: Awareness of the diagnosis of type 2 diabetes may temporarily increase the risk of depressive symptoms. Further research is needed to determine whether more prevalent use of antidepressants noted before the diagnosis of diabetes relates to effects of depression, side effects of antidepressant use, or a common causal pathway for depression and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
The prevalence of psychiatric disorders among cancer patients
Derogatis, L. R. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330300035030 · Cited by 1,575
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Ford, D. E., & Erlinger, T. P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.1010 · Cited by 544 · cited 1×
“Indeed, depression is associated with several behavioral and metabolic factors that can increase the risk of diabetes and insulin resistance, including obesity-promoting health behaviors, such as physical inactivity and hypercaloric diets (10,11) and activation of the neuroendocrine (12) and inflammatory responses (13…”
BackgroundObesity and Type 2 Diabetes Risk in Midadult Life: The Role of Childhood Adversity
Thomas, C., Hyppönen, E., & Power, C. (2008) · Pediatrics · doi:10.1542/peds.2007-2403 · Cited by 330
Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242
Cited by
Depression and type 2 diabetes: A causal association?
Tabák, A. G., Akbaraly, T. N., Batty, G. D., & Kivimäki, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70139-6 · Cited by 167
Self-citationNousen, E. K., Franco, J. G., & Sullivan, E. L. (2013) · Neuroendocrinology · doi:10.1159/000355632 · Cited by 123
Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis
Graham, E. A., Deschênes, S. S., Khalil, M. N., Danna, S., Filion, K. B., & Schmitz, N. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.053 · Cited by 94
Anti-depressant medication use and C-reactive protein: Results from two population-based studies
Hamer, M., Batty, G., Marmot, M. G., Singh-Manoux, A., & Kivimäki, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.013 · Cited by 71
“…medication has been linked with a greater risk of weight gain (Aronne & Segal, 2003), diabetes (Rubin et al., 2008; Andersohn et al., 2009; Kivimäki et al., 2010), and with an increased risk of cardiovascular disease (CVD) events in most (Cohen et al., 2000; Tata et al., 2005; Chen et…”
Self-citationHasan, S. S., Clavarino, A. M., Mamun, A. A., Doi, S. A. R., & Kairuz, T. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.09.008 · Cited by 34
“Studies that examined the association of antidepressant use and DM were also excluded because we assume that antidepressant use may mask the longitudinal relationship between depression and DM (Egberts et al., 1997; Kivimaki et al., 2010; Knol et al., 2009).”
Metadata
- Authors
- Kivimäki, M., Tabák, A. G., Lawlor, D. A., Batty, G. D., Singh-Manoux, A., Jokela, M., Virtanen, M., Salo, P., Oksanen, T., Pentti, J., Witte, D. R., & Vahtera, J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-04-05
- Volume
- 33
- Issue
- 7
- Pages
- 1471-1476
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2129915900
- Cited by
- 53
- References
- 9
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant Use Before and After the Diagnosis of Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc09-2359
- The paper
- Kivimäki, M., Tabák, A. G., Lawlor, D. A., Batty, G. D., Singh-Manoux, A., Jokela, M., Virtanen, M., Salo, P., Oksanen, T., Pentti, J., Witte, D. R., & Vahtera, J. (2010). Antidepressant Use Before and After the Diagnosis of Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc09-2359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.